Article
Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance?
13 Aug 2020
Abstract excerpt
Glioblastoma (GBM) is the most frequent malignant primary brain tumor in adults, characterized by a highly aggressive, inflammatory and angiogenic phenotype. It is a remarkably heterogeneous tumor at several levels, including histopathologically, radiographically and genetically. The 2016 update of the WHO Classification of Tumours of the Central Nervous System highlighted molecular parameters as paramount...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
